CIS
HRMY icon

Connors Investor Services’s Harmony Biosciences HRMY Stock Holding History

Connors Investor Services’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-69,722
Closed -$2.61M – 159
2025
Q4 		$2.61M Sell
69,722
-1,975
-3% -$64.9K 0.22% 76
2025
Q3 		$1.98M Sell
71,697
-1,303
-2% -$44.9K 0.17% 83
2025
Q2 		$2.31M Buy
73,000
+206
+0.3% +$6.63K 0.2% 85
2025
Q1 		$2.42M Buy
72,794
+102
+0.1% +$3.66K 0.24% 72
2024
Q4 		$2.5M Buy
+72,692
New +$2.5M 0.23% 80

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Connors Investor Services's HRMY Position: Q1 2026 in Review

Connors Investor Services sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 69,722 shares — an estimated $2.61M sold.

Connors Investor Services first reported a position in HRMY in Q4 2024 and held it in 5 quarters. The position peaked at $2.61M in Q4 2025. 311 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • Connors Investor Services reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • Connors Investor Services sold 69,722 Harmony Biosciences shares in Q1 2026, an estimated $2.61M.
  • Connors Investor Services first reported a position in Harmony Biosciences in Q4 2024 and held it in 5 quarters.
  • Connors Investor Services's Harmony Biosciences position peaked at $2.61M in Q4 2025.
  • 311 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on Connors Investor Services's 13F filing for Q1 2026, filed 15 May 2026.